A. Cerovecki

发表

Neural correlates (ERP/fMRI) of voluntary selection in adult ADHD patients

C. Mulert, T. Meindl, O. Pogarell, 2010, European Archives of Psychiatry and Clinical Neuroscience.

Increased γ oscillations during voluntary selection processes in adult patients with attention deficit/hyperactivity disorder.

O. Pogarell, M. Riedel, G. Leicht, 2012, Journal of psychiatric research.

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.

V. Arolt, M. Schwarz, M. Riedel, 2011, Journal of affective disorders.

Intact emotion–cognition interaction in schizophrenia patients and first-degree relatives: Evidence from an emotional antisaccade task

H. Möller, U. Habel, B. Derntl, 2013, Brain and Cognition.

Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations

H. Volz, M. Riedel, A. Cerovecki, 2013, CNS Drugs.

Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone

H. Möller, M. Obermeier, M. Riedel, 2010, Human psychopharmacology.

High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib

V. Arolt, M. Schwarz, M. Riedel, 2017, Front. Psychiatry.

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

H. Möller, V. Arolt, M. Schwarz, 2006, Molecular Psychiatry.

Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.

H. Möller, M. Obermeier, M. Riedel, 2010, Pharmacopsychiatry.

Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment

H. Möller, M. Obermeier, B. Bondy, 2017, Cognitive neuropsychiatry.

Globus pallidus internus‐deep brain stimulation in Tourette's syndrome: Can clinical symptoms predict response?

K. Bötzel, J. Mehrkens, S. Dehning, 2011, Movement disorders : official journal of the Movement Disorder Society.

Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics

H. Möller, B. Bondy, M. Riedel, 2008, European Archives of Psychiatry and Clinical Neuroscience.

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia

H. Möller, M. Riedel, I. Spellmann, 2007, European Archives of Psychiatry and Clinical Neuroscience.

Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.

D. Rujescu, I. Giegling, H. Möller, 2011, Journal of psychiatric research.

Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

D. Rujescu, I. Giegling, H. Möller, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Globus pallidus internus‐deep brain stimulation in Tourette's syndrome: Can clinical symptoms predict response?

J. Mehrkens, S. Dehning, A. Cerovecki, 2011, Movement disorders : official journal of the Movement Disorder Society.

Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone

H. Möller, M. Obermeier, I. Spellmann, 2010, Human psychopharmacology.